TIGIT is a key inhibitory checkpoint receptor in lymphoma
TIGIT是淋巴瘤中的关键抑制性检查点受体。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006582
Godfrey, James; Chen, Xiufen; Sunseri, Nicole; Cooper, Alan; Yu, Jovian; Varlamova, Arina; Zarubin, Dmitry; Popov, Yuriy; Jacobson, Connor; Postovalova, Ekaterina; Xiang, Zhongmin; Nomie, Krystle; Bagaev, Aleksander; Venkataraman, Girish; Zha, Yuanyuan; Tumuluru, Sravya; Smith, Sonali M; Kline, Justin P